SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-013060
Filing Date
2016-02-10
Accepted
2016-02-10 20:32:20
Documents
2
Period of Report
2016-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5012
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 5007
  Complete submission text file 0000899243-16-013060.txt   11686
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 DUBLIN 2
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN L2 DUBLIN 2 353 1 709 4000
Elan Science One Ltd (Reporting) CIK: 0001565579 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 161407606